Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins

Creative Commons License

Sahin E., MADENDAĞ Y., SAHIN M. E., MADENDAG I. C., AÇMAZ G., Karakukcu C., ...Daha Fazla

CANCER CONTROL, cilt.25, sa.1, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1177/1073274818798598
  • Dergi Adı: CANCER CONTROL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: cervical immune response, human papillomavirus, high-risk HPV, LGSIL, HGSIL, secretory leukocyte protease inhibitor (SLPI), LEUKOCYTE PROTEASE INHIBITOR, CANCER, EXPRESSION, INDUCTION
  • Erciyes Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate cervical mucus secretory leukocyte protease inhibitor (SLPI) concentrations in patients with high-risk human papillomavirus (hrHPV) 16 or 18 positive and low-grade squamous intraepithelial lesions (LGSIL) or high-grade squamous intraepithelial lesions (HGSIL).